It seems there was an error, as the content you provided is marked as "undefined." Please provide specific content for summarization.
AZN has been in the news recently: A U.S. federal judge dismissed challenges from pharmaceutical companies, including AstraZeneca, against Maine's regulation of contract pharmacies under the 340B program. Factor Bioscience Inc. has filed a patent infringement complaint against AstraZeneca, alleging violations related to essential gene-editing patents for cancer therapies.
📡️ Health Care
In The News
More Signals
Feature in Progress
This section is under development. Check back soon for updates!
Cashu is the #1 way to stay ahead of the markets, know why your favourite stocks are moving and access valuation signals that smash the market.